Compare State Street SPDR S&P Biotech ETF (XBI) vs Financial Select Sector SPDR Fund (XLF) Price & Performance

State Street SPDR S&P Biotech ETFTrade

Financial Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

State Street SPDR S&P Biotech ETF vs Financial Select Sector SPDR Fund — how do they compare? State Street SPDR S&P Biotech ETF trades at $154.43, while Financial Select Sector SPDR Fund trades at $56.13. Which is the better fit depends on your goals.

	XBI	XLF
Sector	Broad Market / Factor	—
52-Week High	$164.28	$56.75
52-Week Low	$85.16	$47.80

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

XBI

Healthcare ETFs lead State Street's top 5 performers with pharma fund gaining 11.7% in the past monthETF Trends · 4 days agoBullish View details →

XLF

Financial sector offers undervalued opportunities beyond AI with XLF ETF providing broad, cost-effective exposure.24/7 Wall Street · 5 hours agoBullish John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 16 hours agoBullish View details →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

About Financial Select Sector SPDR Fund

The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.